Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System (Q33288486)

25 July 2017

Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System (English)

1 reference

25 July 2017

1 reference

Benjamin Littenberg

3

0 references

Charles D. MacLean

series ordinal

2

object named as

Charles D MacLean

1 reference

25 July 2017

Maria E Ramos-Nino

1

1 reference

PubMed ID

17584937

25 July 2017

language of work or name

English

0 references

publication date

21 June 2007

1 reference

25 July 2017

1 reference

25 July 2017

5

1 reference

25 July 2017

17

1 reference

https://scigraph.springernature.com/pub.10.1186/1741-7015-5-17

25 July 2017

0 references

cites work

Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

Thiazolidinediones, insulin resistance and obesity: Finding a balance.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

Limitations of diabetes pharmacotherapy: results from the Vermont Diabetes Information System study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

Diabetes, insulin, and risk of cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

Investigational PPAR-gamma agonists for the treatment of Type 2 diabetes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

Attenuation of peroxisome proliferator-activated receptor gamma (PPARgamma) mediates gastrin-stimulated colorectal cancer cell proliferation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

Function of PPARgamma and its ligands in lung cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

PPAR gamma and human metabolic disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

Recent findings concerning thiazolidinediones in the treatment of diabetes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

The Vermont Diabetes Information System (VDIS): study design and subject recruitment for a cluster randomized trial of a decision support system in a regional sample of primary care practices

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

21 June 2018

Smoking and lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

Sulfonylurea agents exhibit peroxisome proliferator-activated receptor gamma agonistic activity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

Oral antihyperglycemic therapy for type 2 diabetes mellitus.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

GW9662, a potent antagonist of PPARgamma, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARgamma agonist rosiglitazone, independently of PPARgamma activation.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

Diabetes mellitus and the risk of prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

Thiazolidinediones enhance skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-5-17

Thiazolidinedione anti-cancer activity: Is inhibition of microtubule assembly implicated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-5-17

Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-5-17

Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-5-17

Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-5-17

Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-5-17

Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-5-17

Cigarettes, alcohol, and depression: characterizing head and neck cancer survivors in two systems of care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-5-17

Validity of the mental health component scale of the 12-item Short-Form Health Survey (MCS-12) as measure of common mental disorders in the general population.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1934377

Diabetes and Risk of Prostate Cancer in a Prospective Cohort of US Men

31 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-5-17

Epidemiology of hepatocellular carcinoma in Finistère. Prospective study from June 2002 to May 2003

21 January 2018

1 reference

12 December 2020

The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research

1 reference

12 December 2020

Effect of rosiglitazone on N-nitroso-N-methylurea-induced mammary tumors in rat

1 reference

12 December 2020

Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study

1 reference

12 December 2020

Women younger than 50 years with endometrial cancer

1 reference

12 December 2020

Prostate cancer risk among men with diabetes mellitus (Spain)

1 reference

12 December 2020

Identifiers

DOI

10.1186/1741-7015-5-17

1 reference

PubMed ID

17584937

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference

PubMed ID

17584937